Researchers at the University of Colorado Anschutz Medical Campus discovered LL-341070, a drug that restores vision in ...

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...